|
|
 |
| |
 |
Xalatan, the leading glaucoma medication in every major worldwide market, is indicated for the treatment of open-angle glaucoma and ocular hypertension. Xalatan, once daily,reduces IOP by up to 35%. Its efficacy is consistent and long lasting. It has good systemic tolerability and added IOP reduction in combination with other anti-glucoma drugs.
|
| |
|
|
|
|
|
 |
|
